Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry

NCT06577597 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Tract Infections

Interventions

DRUG: GSK3923868
DRUG: Placebo

Sponsor

GlaxoSmithKline